Impact of terminal dimethylation on the resistance profile of α-N-heterocyclic thiosemicarbazones-Reference-Cited by-同舟云学术

Impact of terminal dimethylation on the resistance profile of α-N-heterocyclic thiosemicarbazones

Published:2012-06 Issue:12 Volume:83 Page:1623-1633
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Heffeter Petra,Pirker Christine,Kowol Christian R.,Herrman Gerrit,Dornetshuber Rita,Miklos Walter,Jungwirth Ute,Koellensperger Gunda,Keppler Bernhard K.,Berger Walter

Funder

Austrian Science Fond (FWF)

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference39 articles.

1. Phase I and pharmacodynamic study of Triapine, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia;Giles;Leuk Res,2003

2. A Phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disorders

3. A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas;Attia;Invest New Drug,2008

4. A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine((R))) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells;Ma;Invest New Drug,2008

5. Phase II study of Triapine in patients with metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada Clinical Trials Group (NCIC IND.161);Knox;Invest New Drug,2007

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Schiff bases and their metal complexes to target and overcome (multidrug) resistance in cancer;European Journal of Medicinal Chemistry;2024-04

2. Thiosemicarbazone Derivatives Developed to Overcome COTI-2 Resistance;Cancers;2022-09-14

3. Cancer Cell Resistance Against the Clinically Investigated Thiosemicarbazone COTI-2 Is Based on Formation of Intracellular Copper Complex Glutathione Adducts and ABCC1-Mediated Efflux;Journal of Medicinal Chemistry;2020-11-16

4. Selenotriapine – An isostere of the most studied thiosemicarbazone with pronounced pro-apoptotic activity, low toxicity and ability to challenge phenotype reprogramming of 3-D mammary adenocarcinoma tumors;Arabian Journal of Chemistry;2020-01

5. Anticancer Thiosemicarbazones: Chemical Properties, Interaction with Iron Metabolism, and Resistance Development;Antioxidants & Redox Signaling;2019-03-10